Editorial · 25 Aug 2020
Conference abstractPublished 10 Mar 2022
Stem cell therapy in End -stage constrictive Pericarditis
Morning Star hospital, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The so-called “ inflammatory hypothesis ”is now a targeted, therapeutic area in clinical and experimental cardiology. Antiinflammatory agents have no benefit and associated with side effects.The rationale of stem cell therapy therapy is to improve blood supply to the ischemic areas of heart, decrease cardiac fibrosis and cardiac muscle apoptosis. In constrictive pericarditis, the thickened, fibrous pericardium that form a non-complaint shell around the heart, inhibits the diastolic filling. “End-stage” constrictive pericarditis has posed a diagnostic dilemma since it presented with features of right-sided heart failure. Etiology remains unknown in majority of case and inflammatory process play a central role in its development. Pericardium resection (or pericardial stripping) is a surgical procedure where the entire pericardium is pealed away from the heart. In advanced (end-stage) constrictive pericarditis, pericardiectomy may not offer a cure or desired long term results. Amniotic stem cell therapy consisting of either stem cells with extracellular matrix or extracellular matrix alone in the form of human amniotic membrane allograft, an emerging anti-inflammatory and antifibrotic treatment and four human allograft membranes were topically placed over the right atrium, right ventricle and left ventricle prior to closure. In postoperative cardiac MRI, septal bounce during Valsalva suggesting ventricular inter-dependance and biatrial enlargement with dilated IVC and hepatic veins were absent. After 5 week, post operative fat-suppression T2 weighted MRI revealed no inflammation and pericardial effusion. Stem cells promote cardiac cell regeneration through direct and paracrine factors, decreases cardiac muscle apoptosis and improves blood supply to ischemic regions of the heart.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 19 Mar 2018
The merits of autologous mesenchymal stem cells peripheral vein infusion in patients suffering from end stage liver cirrhosis
Conference abstract · 24 Jun 2014
Human fetal liver progenitor cell transplantation: A potential bridging therapy to liver transplantation in patients with end-stage liver disease
Conference abstract
STEM CELL THERAPY IN END-STAGE LIVER DISEASE AND LIVER FAILURE
Conference abstract · 19 Mar 2018
Illustrated evaluation of scientific productions of Iranian stem cell researchers during 2011 till the end of 2015
More from this journal
The newest in Journal of Cell Science & Therapy.
Perspective · 2 Feb 2026
Exploring Senescence and Its Influence on Tissue Function and Therapeutic Research
Commentary · 2 Feb 2026
Metabolism Regulation and Its Influence on Therapeutic Development in Human Disease
Commentary · 2 Dec 2025
Cellular Membranes and Transport Proteins as Regulators of Homeostasis and Metabolic Coordination
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Cell Science & Therapy
- SubjectBiology
- BylineArticles whose byline prints “Ramachandran Muthiah”

